Finance


CBD Makes Its Way into Mainstream Retail

November 19th, 2020 - Ryan Allway

The U.S. market for CBD products is projected to reach $23.7 billion by 2023, according to Brightfield Group, representing a seven-fold increase in the market’s size. While it’s one of the fastest-growing subsets of the multi-trillion-dollar wellness industry, CBD products remain absent from most mass-market retailers. CVS became the first large-scale retailer to offer CBD […]

California Cannabis Industry to Hit $6 Billion by 2025

November 16th, 2020 - Ryan Allway

California’s cannabis industry is on track to surpass $6 billion in 2025, according to BDS Analytics, which would represent a sixth of legal cannabis sales in the United States. Although Nevada and a handful of other states experienced COVID-19-related disruptions, California’s mature market has managed to weather the pandemic thus far. Let’s take a closer […]

CB Therapeutics: Producing Rare Cannabinoid & Psychedelic Molecules at Scale

November 10th, 2020 - Ryan Allway

The cannabis industry has evolved from the legalization of dried cannabis to an increasingly detailed understanding of individual cannabinoids. While THC and CBD are the two most common, researchers are increasingly interested in CBC, THCV and other rare cannabinoids that could have specific and desirable effects on certain medical indications. The problem is that these […]

MagicMed Shortcuts Commercialization Timeline with University Agreement

November 4th, 2020 - Ryan Allway

Most pharmaceutical and biotech investors are familiar with long commercialization timelines, but there are a few ways to shortcut the process. For example, the Food and Drug Administration provides Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review designations for certain therapies targeting life-threatening conditions. MagicMed Industries Inc., a developer of licensable psychedelic molecular derivatives, […]

3 Psychedelische Business Modelle (und was am besten für Investoren ist)

October 23rd, 2020 - Ryan Allway

Die Psychedelikaindustrie hat das Interesse von Pharmaunternehmen geweckt, die nach sichereren und effektiveren Produkten suchen, um ungedeckte medizinische Bedürfnisse im Bereich der psychischen Gesundheit zu befriedigen. Während psychedelische Moleküle vielversprechend sind, verlangen die Pharmahersteller, dass die Moleküle durch wissenschaftliche Techniken verbessert werden, um bestimmte therapeutische Ziele zu erreichen und Toxizitäten zu reduzieren. Es gibt drei […]

Cybin Raises C$45 Million: The Largest Go Public Capital Raise in the Canadian Psychedelic Sector

October 22nd, 2020 - Ryan Allway

The COMPASS Pathways Inc. (NASDAQ: CMPS) initial public offering on the NASDAQ has reinvigorated the psychedelics industry over the past couple of weeks. While COMPASS Pathways Inc. is certainly one of the largest companies in the space, there are a handful of other companies, with experienced management teams, that have raised a significant amount of […]

3 Psychedelic Business Models (and What’s Best for Investors)

October 22nd, 2020 - Ryan Allway

The psychedelics industry has captured the interest of pharmaceutical companies seeking safer and more effective products to address unmet medical needs in mental health. While psychedelic molecules have shown promise, pharmaceutical manufacturers are likely to require that the molecules be improved through scientific engineering to meet specific therapeutic goals and reduce toxicities. There are three […]

ManifestSeven: From Railroads to Fiber in California’s Cannabis Industry

October 20th, 2020 - Ryan Allway

California has the world’s largest cannabis market with an estimated $12 billion in annual sales. While legal cannabis sales topped $3 billion last year, the state continues to struggle to meet high expectations with logistical and other challenges. ManifestSeven Holdings Corporation (CSE: MSVN), which recently debuted on the Canadian Securities Exchange on September 30, aspires […]

Christina Lake Cannabis: Disrupting the Market with Ultra-Low Cost Production

September 17th, 2020 - Ryan Allway

Cannabis is quickly moving from a hot commodity to a regular commodity as a growing number of licensed producers put pressure on prices. While the government hopes that falling prices push out black market competition, many companies have seen their margins contract after just a short time in production—spelling danger for investors in the space. […]

Israel Gives Final Go-Ahead for Cannabis Exports: Here’s Who Could Profit

June 5th, 2020 - Ryan Allway

Israel gave final approval in mid-May for exports of medical cannabis, paving the way for more than one billion shekels ($273 million) in annual revenue. The country will become one of just three countries that have approved the export of medical cannabis to countries that permit its use—after Canada and the Netherlands— when the law […]

How to Invest in a Global Cannabis Portfolio

May 20th, 2020 - Ryan Allway

North America’s cannabis industry may capture the most headlines, but there are many cannabis frontier markets to keep in mind. In fact, North America represented just 25%, or $86 billion, of the $344 billion global cannabis market in 2018, according to New Frontier Data. Asia, Europe, Africa, Latin America, Oceana and the Caribbean are all […]

THC BioMed Reports Growing Revenue & Profitability

April 22nd, 2020 - Ryan Allway

Cannabis investors had already been shifting from “unproven potential” to “profitability” over the past several quarters prior to the global health crisis. With the COVID-19 outbreak, investors have fled previous investments to profitable companies that aren’t reliant on costly or dilutive funding to sustain their operations. THC BioMed Intl Ltd. (CSE: THC) recently recorded its […]

Ehave, Inc. Appoints Dr. Mark Braunstein as Chief Psychedelic Officer

April 6th, 2020 - Ryan Allway

Dr. Braunstein is recognized worldwide in Psychedelic Psychiatry, which entails treating psychiatric disorders with psychedelics Dr. Braunstein is a renowned expert on psychedelic therapy and addiction. As a pioneer in psychedelic medicine research, he specializes in the treatment of ADHD, depression, anxiety, bipolar disorder, substance abuse, oppositional defiance, personality disorders, and treatment resistance. He has […]

Science-driven Brand Delivers 5 Perfected Cannabis Highs

April 6th, 2020 - Robin Lefferts

What happens when the investment environment surrounding cannabis companies evaporates amid concerns about overvaluations and lack of returns? And then, a worldwide pandemic reverses years of economic growth almost overnight, plunging economies into near-instant depression? One thing that happens is some quality companies become distressed, offering investors the opportunity to purchase a stake at a […]

Cannabis Brands Want Their Own Store, CalEthos Deems it Essential

April 3rd, 2020 - Robin Lefferts

Cannabis Shelf Space Deemed Essential What is the ideal setting for a brand to showcase its wares to the retail consumer? It is certainly not a crowded store with hundreds of brands competing for limited shelf space and consumer attention. Every brand out there would much rather have its own store, featuring its own product […]

Coping With Stress During the COVID-19 Outbreak with CBD & Adaptogens

April 2nd, 2020 - Ryan Allway

The COVID-19 outbreak has become a major source of stress over the past several weeks. In addition to the fear and anxiety of disease, quarantines and “stay at home” orders have contributed to stress levels, leading to poor sleep, unhealthy eating, and other side-effects. It’s important for everyone to take inventory of their health and […]

5 Ways to Participate in the Psychedelics Boom

March 27th, 2020 - Ryan Allway

The psychedelics industry is quickly becoming the next frontier market for investors as the cannabis industry matures. Through a combination of cutting-edge research and decriminalization, investors are hoping that the industry moves in the same direction as medical cannabis over the coming years. Let’s take a look at five public companies in the space and […]

CannaTrac’s Diversified Revenue Streams Create a Baseline for Consistent, Sustainable Growth

March 25th, 2020 - Ryan Allway

The legal cannabis industry has had its ups and downs since its inception just a few years ago. Legislation and licensing decisions helped boost some companies, while overcapacity and regulatory issues depressed others. The best companies have found ways to diversify their revenue streams to generate consistent and sustainable growth over time.  In this article, […]

How Cannabis Companies Are Adapting to the ‘New Normal’

March 3rd, 2020 - Ryan Allway

The cannabis industry has shifted its focus from expansion to profitability over the past year. Rather than spending a lot of money to expand into every market, multi-state operators, or MSOs, are starting to pare down their assets and restructure their operations to adapt to the ‘new normal’ — mature markets where profits are king. […]

Out with the Old: How CalEthos Is Giving Brands a Voice and Consumers an Educated Choice

March 3rd, 2020 - Robin Lefferts

For a revolutionary movement, the cannabis industry still seems to have a lot of “same old, same old.” Cannabis brands increasingly must face many of the challenges that other CPG businesses have long confronted – including distribution, retail visibility, and consumer education – while complying with regulations that leave one hand tied behind their backs. […]

The Future of Cannabis Retail Is Here

February 12th, 2020 - Robin Lefferts

Cannabis has been grown and sold illicitly for generations in California. But legal sales of cannabis through retail stores is still relatively new. With black- and gray-market sellers as precursors, most cannabis dispensaries today don’t stray far from the old-school medical dispensary or head-shop model – cramped and crammed with a wide variety of products […]

Supreme Cannabis Focuses Organization and Reduces Cost Structure to Accelerate Profitable Growth

February 11th, 2020 - Ryan Allway

Corporate positions decreased by approximately 33% and operational positions decreased by approximately 13% Total number of positions decreased by approximately 15% across the Company New structure focuses the business on accelerating revenue growth in the Canadian market TORONTO, February 11, 2020 – The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSX: FIRE) (OTCQX: […]

General Cannabis’ SevenFive Farms Acquisition Provides In-Roads to Colorado

February 7th, 2020 - Ryan Allway

Colorado cannabis sales hit $1 billion in total cannabis-related revenue in 2019, becoming the first state in the country to hit that milestone five years after legalization. In addition, Colorado has the highest per-person spending on cannabis at $280 per year, which is significantly higher than the $220 and $130 annual spend in Washington State […]

ManifestSeven Expands Distribution in California with Focus on Women Ahead of Public Listing

February 4th, 2020 - Ryan Allway

ManifestSeven is building California’s first integrated omnichannel platform for legal cannabis by merging compliant distribution with a retail superhighway. With a network of seven distribution facilities stretching from San Francisco to San Diego, the company offers cultivators and product manufacturers a unique venue for distributing and selling their products. Over the past several months, the […]

THC BioMed Intl Ltd. Turns a Profit as Revenue Breaks $1 Million

January 28th, 2020 - Robin Lefferts

Canada’s cannabis sector has experienced a sharp sell-off over the past year, with the Marijuana Index’s Canadian Index moving from a high of $727 in March to a low of $196 in November. Rather than looking solely at growth in production capacity, many investors are shifting their focus to tangible revenue growth and profitability. Profitable […]

Why ‘Second-Mover Advantage’ is Key to Cannabis 3.0

January 26th, 2020 - Ryan Allway

Legal cannabis has become one of the fastest growing industries in history. In less than a decade, it has grown from zero to upwards of $15 billion in global sales, driven by the liberalization of laws around the world. These growth rates are expected to accelerate as more states and countries legalize medical and adult-use […]

Supreme Cannabis 2020, A Simple Approach On The Path To Profitability

January 23rd, 2020 - Ryan Allway

Many expect 2020 to go down as the shakeout year for the Canadian cannabis industry; the year where winners will make their way to the top and companies with weak fundamentals will be ruled out. Of the potential winners, The Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) is one Canadian player that stands out with its […]

CannaTrac Aims to Become the Go-To Payment Solution for Cannabis

January 23rd, 2020 - Ryan Allway

The legal cannabis industry is projected to grow from $12.4 billion in 2019 to $23 billion by 2025, according to New Frontier Data, driven by the liberalization of medical and adult-use laws around the country. While federal regulations have started to catch up, the industry continues to struggle with a lack of access to the […]

Cannafornia strikes deal for Florida Super License, has opportunity to become one of 22 Florida Licensees

January 20th, 2020 - Ryan Allway

SALINAS, Calif. (PRWEB) January 15, 2020 CEO of Cannafornia, Paul King, told us earlier today, “Cannafornia has made a name for itself in the most competitive market in the world, California, where there are over 6,000 active licensees, and a long history of illicit growing and selling. Despite all the challenges, Cannafornia has emerged as […]

What is the Next Stage of Cannabis Investing?

January 13th, 2020 - Ryan Allway

Remember when investments in cannabis and Bitcoin were seen as interchangeable pursuits of the next sky-high return based on a story that sounded plausible, if not downright enticing? In the early days, cannabis investors chased Canadian operators focused on ramping up production to meet the growing demand of a newly legalized Canadian recreation market and, […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading